Polydopamine-based surface modification is a simple way to functionalize polymeric nanoparticle (NP) surfaces with
ligands and/or additional polymeric layers. In this work, we developed DTX-loaded formulations using
polydopamine-modified NPs synthesized using D-α-
tocopherol polyethylene glycol 1000 succinate-
poly(lactide) (pD-
TPGS-PLA/NPs). To target
liver cancer cells,
galactosamine was conjugated on the prepared NPs (Gal-pD-
TPGS-PLA/NPs) to enhance the delivery of DTX via
ligand-mediated endocytosis. The size and morphology of pD-
TPGS-PLA/NPs and Gal-pD-
TPGS-PLA/NPs changed obviously compared with
TPGS-PLA/NPs. In vitro studies showed that
TPGS-PLA/NPs, pD-
TPGS-PLA/NPs and Gal-pD-
TPGS-PLA/NPs had similar release profiles of DTX. Both confocal
laser scanning microscopy and flow cytometric results showed that
coumarin 6-loaded Gal-pD-
TPGS-PLA/NPs had the highest cellular uptake efficiency in
liver cancer cell line HepG2. Moreover, DTX-loaded Gal-pD-
TPGS-PLA/NPs inhibited the growth of HepG2 cells more potently than
TPGS-PLA/NPs, pD-
TPGS-PLA/NPs, and a clinically available DTX formulation (Taxotere®). The in vivo biodistribution experiments show that the Gal-pD-
TPGS-PLA/NPs are specifically targeted to the
tumor. Furthermore, the in vivo anti-
tumor effects study showed that injecting DTX-loaded Gal-pD-
TPGS-PLA/NPs reduced the
tumor size most significantly on
hepatoma-bearing nude mice. These results suggest that Gal-pD-
TPGS-PLA/NPs prepared in the study specifically interacted with the
hepatocellular carcinoma cells through
ligand-receptor recognition and they may be used as a potentially eligible drug delivery system targeting
liver cancers.
STATEMENT OF SIGNIFICANCE:
Polydopamine-based surface modification is a simple way to functionalize polymeric nanoparticle surfaces with
ligands and/or additional polymeric layers. In this work, we developed
docetaxel (DTX)-loaded formulations using
polydopamine-modified NPs synthesized from D-α-
tocopherol polyethylene glycol 1000 succinate-
poly(lactide) (pD-
TPGS-PLA/NPs). To target
liver cancer cells,
galactosamine was conjugated on the prepared NPs (Gal-pD-
TPGS-PLA/NPs) to enhance the delivery of DTX via
ligand-mediated endocytosis. Both confocal
laser scanning microscopy and flow cytometric results showed that
coumarin 6-loaded Gal-pD-
TPGS-PLA/NPs had the highest cellular uptake efficiency for
liver cancer cell line HepG2. The in vivo biodistribution experiments show that the Gal-pD-
TPGS-PLA/NPs are specifically targeted to the
tumor. Furthermore, the in vivo anti-
tumor effects study showed that injecting DTX-loaded Gal-pD-
TPGS-PLA/NPs reduced the
tumor size most significantly on
hepatoma-bearing nude mice. These results suggest that Gal-pD-
TPGS-PLA/NPs prepared in the study specifically interacted with the
hepatocellular carcinoma cells through
ligand-receptor recognition and they could be used as a potentially eligible drug delivery system targeting
liver cancers.